ZA200700772B - Peptidic vasopressin receptor agonists - Google Patents

Peptidic vasopressin receptor agonists

Info

Publication number
ZA200700772B
ZA200700772B ZA200700772A ZA200700772A ZA200700772B ZA 200700772 B ZA200700772 B ZA 200700772B ZA 200700772 A ZA200700772 A ZA 200700772A ZA 200700772 A ZA200700772 A ZA 200700772A ZA 200700772 B ZA200700772 B ZA 200700772B
Authority
ZA
South Africa
Prior art keywords
receptor agonists
vasopressin receptor
peptidic vasopressin
peptidic
agonists
Prior art date
Application number
ZA200700772A
Other languages
English (en)
Inventor
Wisniewski Kazimierz
Laporte Regent
Pierre J-M Riviere
Schteingart Claudio
Galyean Robert Felix
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of ZA200700772B publication Critical patent/ZA200700772B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200700772A 2004-08-11 2007-01-26 Peptidic vasopressin receptor agonists ZA200700772B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04019029 2004-08-11

Publications (1)

Publication Number Publication Date
ZA200700772B true ZA200700772B (en) 2008-09-25

Family

ID=34926126

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700772A ZA200700772B (en) 2004-08-11 2007-01-26 Peptidic vasopressin receptor agonists

Country Status (26)

Country Link
US (2) US8148319B2 (xx)
EP (1) EP1776133B1 (xx)
JP (1) JP4664363B2 (xx)
KR (1) KR100884323B1 (xx)
CN (1) CN1964732B (xx)
AR (1) AR050914A1 (xx)
AT (1) ATE509944T1 (xx)
AU (1) AU2005274070B2 (xx)
BR (1) BRPI0511466B8 (xx)
CA (1) CA2567797C (xx)
DK (1) DK1776133T3 (xx)
ES (1) ES2366702T3 (xx)
HK (1) HK1100280A1 (xx)
IL (1) IL178690A (xx)
JO (1) JO2937B1 (xx)
MX (1) MX2007001396A (xx)
NO (1) NO342449B1 (xx)
NZ (1) NZ550707A (xx)
PL (1) PL1776133T3 (xx)
PT (1) PT1776133E (xx)
RU (1) RU2355701C2 (xx)
SA (1) SA05260254B1 (xx)
SI (1) SI1776133T1 (xx)
TW (1) TWI364291B (xx)
WO (1) WO2006020491A1 (xx)
ZA (1) ZA200700772B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2641959C (en) * 2006-02-10 2016-12-20 Ferring B.V. Novel compounds
ES2566143T3 (es) * 2006-02-13 2016-04-11 Ferring B.V. Uso de agonistas peptídicos de receptor de vasopresina
WO2009037586A2 (en) * 2007-08-14 2009-03-26 Ferring B.V. Use of peptidic vasopressin receptor agonists
EP2343982B1 (en) 2008-09-17 2017-03-22 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
JO3109B1 (ar) * 2012-05-10 2017-09-20 Ferring Bv منبهات لمستقبلات v1a
US9388214B2 (en) 2014-11-05 2016-07-12 Ferring B.V. V1A receptor agonists
RU2634272C1 (ru) * 2016-08-10 2017-10-24 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Композиция с дезамино-аргинин-вазотоцином для парентерального введения и способ её получения
MA46586A (fr) 2016-10-21 2019-08-28 Chiasma Inc Compositions de terlipressine et leurs procédés d'utilisation
US11033601B2 (en) 2017-09-14 2021-06-15 The Regents Of The University Of Colorado, A Body Corporate Selective inhibition of V1b for treating fatty liver
CN109748950B (zh) * 2017-11-02 2020-10-30 深圳翰宇药业股份有限公司 一种固相合成血管升压素受体肽激动剂selepressin的方法
EP3517543B1 (en) * 2018-01-30 2020-11-04 Bachem AG Manufacture of glucagon peptides
JP2022507380A (ja) 2018-11-15 2022-01-18 フェリング ベスローテン フェンノートシャップ 敗血症を治療するための化合物、組成物及び方法
WO2024073445A1 (en) * 2022-09-30 2024-04-04 Ocelot Bio, Inc. Mixed vasopressin receptor agonist-antagonist for modulating mean arterial pressure

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE651400A (xx) 1963-04-05 1965-02-04
NL129421C (xx) * 1963-08-30 1900-01-01
CS235151B1 (cs) 1982-08-26 1985-05-15 Michal Lebl Způsob dělení Dal isomerů analogů oxytocinu
US4829051A (en) 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
CS242062B1 (cs) 1984-08-23 1986-04-17 Milan Zaoral Vasopresinová a vasotocinová analoga a způsob jejich přípravy
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
SE469473B (sv) 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider
SE502644C2 (sv) * 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
RU2063979C1 (ru) 1992-02-24 1996-07-20 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Пептиды последовательности окситоцина
US5516795A (en) * 1994-09-12 1996-05-14 Abbott Laboratories Heteroatom substituted propanyl derivatives having 5-lipoxygenase inhibitory activity
GB9617021D0 (en) 1996-08-13 1996-09-25 Salpep Biotechnology Inc Novel peptides for treatment of inflammation and shock
SE9701161D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I
SE9701162D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
AU9484798A (en) 1997-09-11 1999-03-29 Public Health Research Institute Of The City Of New York, Inc., The Enhancement of mucosal antibody responses by interleukin-6
IL138214A0 (en) 1998-03-09 2001-10-31 Zealand Pharmaceuticals As Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE0001440D0 (sv) 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
WO2002064740A2 (en) 2001-02-09 2002-08-22 Cognetix, Inc. Cone snail peptides
AU2003220919A1 (en) * 2002-03-29 2003-10-13 Wakamoto Pharmaceutical Co., Ltd. Drugs for increasing lacrimal fluid
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
ATE477811T1 (de) 2002-10-03 2010-09-15 Neuropharmacology Services Llc Oxytocin zur behandlung von autismus und asperger-syndrom
WO2004075783A2 (en) 2003-02-26 2004-09-10 Landry Donald W A method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2641959C (en) * 2006-02-10 2016-12-20 Ferring B.V. Novel compounds
ES2566143T3 (es) * 2006-02-13 2016-04-11 Ferring B.V. Uso de agonistas peptídicos de receptor de vasopresina
JP2010513484A (ja) 2006-12-20 2010-04-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｒｎａ依存性ｒｎａウイルス感染治療用ヌクレオシド環状ホスホロアミデート
RU2342949C1 (ru) 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя

Also Published As

Publication number Publication date
SI1776133T1 (sl) 2011-07-29
DK1776133T3 (da) 2011-07-18
MX2007001396A (es) 2007-04-19
WO2006020491A1 (en) 2006-02-23
CA2567797C (en) 2012-07-10
AU2005274070A1 (en) 2006-02-23
AR050914A1 (es) 2006-12-06
PT1776133E (pt) 2011-09-02
US20120196808A1 (en) 2012-08-02
NZ550707A (en) 2010-07-30
AU2005274070B2 (en) 2008-02-07
IL178690A0 (en) 2007-02-11
BRPI0511466A (pt) 2007-12-26
JO2937B1 (en) 2016-03-15
PL1776133T3 (pl) 2011-09-30
TW200612976A (en) 2006-05-01
TWI364291B (en) 2012-05-21
CN1964732B (zh) 2011-03-02
NO342449B1 (no) 2018-05-22
KR20070029183A (ko) 2007-03-13
RU2355701C2 (ru) 2009-05-20
KR100884323B1 (ko) 2009-02-18
RU2007101238A (ru) 2008-09-20
JP4664363B2 (ja) 2011-04-06
EP1776133B1 (en) 2011-05-18
IL178690A (en) 2013-10-31
JP2008509221A (ja) 2008-03-27
EP1776133A4 (en) 2008-12-31
US8778881B2 (en) 2014-07-15
HK1100280A1 (en) 2007-09-14
NO20071314L (no) 2007-05-10
EP1776133A1 (en) 2007-04-25
CA2567797A1 (en) 2006-02-23
US20090054309A1 (en) 2009-02-26
BRPI0511466B1 (pt) 2018-01-23
CN1964732A (zh) 2007-05-16
SA05260254B1 (ar) 2008-05-19
ES2366702T3 (es) 2011-10-24
ATE509944T1 (de) 2011-06-15
BRPI0511466B8 (pt) 2021-05-25
US8148319B2 (en) 2012-04-03

Similar Documents

Publication Publication Date Title
IL178690A0 (en) Peptidic vasopressin receptor agonists
TWI346553B (en) Chemokine receptor antagonists
ZA200705674B (en) Peptides with neuropeptide-2 receptor (Y2R) agonist activity
EP1729790A4 (en) AMPHIPATHIC GLYCOPEPTIDES
EP1722808A4 (en) EGF RECEPTOR EPITOD PEPTIDES AND THEIR USES
EP1763776A4 (en) SERVICE-ORIENTED ARCHITECTURE
ZA200702790B (en) Thrombin receptor antagonists
EP1874302A4 (en) ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
IL189922A0 (en) Selective vpac2 receptor peptide agonists
ZA200700895B (en) Polypeptide
IL182024A0 (en) Peptide cyclisation
ZA200610812B (en) Keratin-binding polypeptides
HK1117071A1 (zh) 肽加壓素受體激動劑的用途
ZA200704526B (en) G Protein coupled receptor
GB0414798D0 (en) Receptor
GB0415196D0 (en) Polypeptide
GB0402904D0 (en) Polypeptide
ZA200702296B (en) Peptide cyclisation
GB0413872D0 (en) Receptor
GB0413096D0 (en) Receptor
GB0417119D0 (en) Receptor
GB0404584D0 (en) Receptor
GB0427025D0 (en) Receptor
GB0404309D0 (en) Receptor
GB0423327D0 (en) Receptor